Brind.

Recursion Pharmaceuticals experienced a decline on June 21, 2025, which lagged the losses of the S&P 500. The company was also placed into an industry group.

1 report, 0 independent Updated Jun 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Recursion Pharmaceuticals experienced a decline on June 21, 2025, which lagged the losses of the S&P 500. The company was also placed into an industry group.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Unknown outlet